small molecule

E.E.S.

ERYTHROMYCIN ETHYLSUCCINATE

Loss of exclusivity—loss of exclusivity

CompanyAzurity Pharmaceuticals →See this company's full patent-cliff portfolio

Drug detail

Brand name	E.E.S.
Active ingredient	ERYTHROMYCIN ETHYLSUCCINATE
Strength	EQ 200MG BASE
Dosage form	TABLET, CHEWABLE
Route	ORAL
Modality	Small molecule
Marketing status	DISCN

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.